(BDX) Becton, Dickinson and Co Receives FDA Clearance

December 9th, 2009

Becton, Dickinson and Co. (BDX) recently announced that BD Diagnostics, a segment of BDX, has received U.S. Food and Drug Administration (FDA) clearance to utilize its BD ProbeTec Chlamydia trachomatis (CT) Qx and BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assays with samples collected from women’s routine liquid-based Pap testing for cervical cancer screening.

The BD ProbeTec Qx Amplified DNA Assays are the first to receive FDA clearance for gynecological specimens collected and transported for Pap testing in cervical cancer. Pap testing is one of the two leading types of liquid-based cytology (LBC) preservative media on the market today. Pap Testing uses detachable-head collection devices that ensure that 100% of collected cells are sent to the laboratory for analysis.

The ability to test for chlamydia and gonorrhea while screening for cervical cancer provides physicians more information on patients enabling them to take important patient care decisions. It is seen that if left untreated, chlamydia and gonorrhea in women can lead to infertility, pelvic inflammatory disease, ectopic pregnancy and chronic pelvic pain. According to the U.S. Centers for Disease Control and Prevention, more than 1.1 million chlamydia cases were reported in 2007.

Becton, Dickinson and Co. develops, manufactures and markets medical devices, supplies, laboratory equipment and diagnostic products globally. The company is a world leader in safety needle products. Becton competes with players like Baxter International Inc. (BAX), Johnson & Johnson (JNJ) and Abbott Laboratories (ABT).

Zacks Investment Research

Related Posts:

  1. (BDX) Becton, Dickinson and Company Acquires HandyLabBecton, Dickinson and Company (BDX) recently completed the acquisition of HandyLab, Inc, an Ann Arbor,...
  2. (BDX) Becton, Dickinson and Co Reports Strong ResultsBecton, Dickinson and Co. (BDX) reported strong fourth quarter and full fiscal 2009 results. For...
  3. (BDX) Becton-Dickinson and Company Set for Acquisition of HandyLabBecton-Dickinson and Company (BDX) is set to acquire HandyLab Inc., an Ann Arbor, Michigan-based company...
  4. (BDX) Becton, Dickinson and Co. Receives FDA Approval on Blood Collection DeviceBecton, Dickinson and Co. (BDX) announced that it received Food and Drug Administration (FDA) approval...
  5. (BDX) Becton, Dickinson and Company Receives $52 Million Government OrderBecton, Dickinson and Company (BDX) received an order from the Biomedical Advanced Research and Development...
  6. (BDX) Becton, Dickinson and Company – offers an industry-leading yield of 2%Becton, Dickinson and Company (BDX) recently declared a quarterly dividend of 33 cents per share,...


Search Posts by Tag: | | | | | | | | | | Healthcare

RSS Feeds by Tag: Abbott Laboratories | ABT | BAX | Baxter International Inc | BDX | Becton Dickinson Company | Capital Trust | CT | JNJ | Johnson & Johnson | Healthcare |

Other Posts by: | RSS Feed for this author